Report : Superdisintegrants Market to 2027 - Global Analysis and Forecasts By Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases), and Geography
Tablets segment is expected to grow at a fast pace over the forecast period
According to The Insight Partners market research study of ‘‘Superdisintegrants Market to 2027 – Global Analysis and Forecasts by Type, Formulation, Therapeutic Area, Application’ the global Superdisintegrants market is projected to reach US$ 659.17 Mn in 2027 from US$ 369.56 Mn in 2019. The market is projected to grow with a CAGR of 7.6% from 2020-2027. The report provides trends predominating in the global superdisintegrants market and the factors driving the market and also the factors that act as hindrances
The global Superdisintegrants market, based on the formulation, was segmented into tablets and capsule. In 2019, the tablets segment held the largest share of the market. Moreover, the tablets segment is expected to grow at the fastest rate during the coming year. Tablets are the most prescribed solid dosage form for any disease condition hence they are expected to witness significant growth during the forecast period. The other significant factor driving the growth of the market is the adoption of tablets is considerably high as it offers better dosage administration and uniformity.
The significant factors fuelling the market growth are growing adoption of orally disintegrating drugs and increasing acceptability of generic drugs. However, the high cost associated with manufacturing of superdisintegrants is expected to hamper the market during the forecast period.
The Superdisintegrants market majorly consists of players such as Ashland Inc., Basf SE, DowDupont, JRS Pharma, DFE Pharma, Roquette, Asahi Kasei Corporation, Merck KGAA, Corel Pharma Chem, Avantor Performance Materials, LLC., and others. Several companies are concentrating on organic strategies, such as product launch and product approvals. For instance, in April 2018, the partnership of Perrigo Company Plc and Dexcel Pharma Technologies Ltd. launched Omeprazole ODT—orally disintegrating tablets to treat heartburn. The company took strategic step to expand geriatric customer base.
The report segments global Superdisintegrants market as follows:
Global Superdisintegrants Market – By Type
Global Superdisintegrants Market – By Formulation
Global Superdisintegrants Market – By Therapeutic Area
Global Superdisintegrants Market – By Application
Global Superdisintegrants Market – By Geography
Contact Person: Sameer Joshi
Email Id: email@example.com